Trending

Limitless X

Limitless X In Play, Targets Niche Markets In Multi-Billion Dollar Wellness Market ($VYBE)

Keep an eye on Limitless X (OTCQB: VYBE), a small-cap, low-float company positioned to capitalize on revenue-generating opportunities from the over $4 trillion global health and wellness sector. Better yet, instead of just watching it, think about adding it to the speculative buy list, a consideration justified by VYBE being an under-the-radar value investment opportunity presenting ground-floor pricing. But know this. The window of opportunity could close quickly. In fact, with serial and proven entrepreneur Jas Mathur taking on the

Limitless X In Play, Targets Niche Markets In Multi-Billion Dollar Wellness Market ($VYBE) Read More »

KULR Technology

KULR Technology Shares Rally After Announcing Follow-On Order For Its PPR Battery Solutions Technology ($KULR)

KULR Technology, Inc. (NYSE: KULR) is bucking the bearish trend on Wednesday, moving higher to $1.38 after announcing another revenue-generating deal from its innovative and IP-protected Passive Propagation Resistant (PPR) battery solutions technology. The move higher could trigger the break from consolidation around the $1.24 level in February. Shares touched a high of $1.38 intraday on Wednesday but gave back some of those gains as broader market sentiment again turned bearish red. Still, better positioned now than at any time

KULR Technology Shares Rally After Announcing Follow-On Order For Its PPR Battery Solutions Technology ($KULR) Read More »

RenovoRx, Inc.’s RenovoTAMP Platform On Pace To Change Cancer Treatment Landscape ($RNXT)

RenovoRx, Inc. (NASDAQ: RNXT) shares are bucking the bearish trend. Since the new year, RNXT stock has been trading higher by over 54%, decoupling from the broader weakness in the small-cap biotech space. With impressive YTD gains, RXNT is better positioned now than when its stock scored a $5.00 mark last month, and following its latest announcements, a more than 38% move higher in the near term could be in play. That bullish presumption is justified as the latest news

RenovoRx, Inc.’s RenovoTAMP Platform On Pace To Change Cancer Treatment Landscape ($RNXT) Read More »

Global Electrification Is Happening Shockingly Fast And KULR Could Surge With It ($KULR)

The world is getting electrified. And KULR Technology (NYSE: KULR) intends to ensure it’s done safely. Make no mistake, manufacturers and consumers need what KULR sells, especially with billions of products, including household tools, toys, and even hypersonic missiles integrating the extraordinary power of lithium-ion energy sources. But there’s a problem looming. In fact, it’s an issue that’s far from secret- if these powerfully and densely packed energy sources aren’t required to integrate available battery safety technology, like KULR’s, headlines

Global Electrification Is Happening Shockingly Fast And KULR Could Surge With It ($KULR) Read More »

Low-Float Avalon GloboCare Positions For A Bullish 2023 ($ALBT)

Markets are dynamic. And with just a slight imbalance between buyers and sellers, more times than not, an opportunity gets exposed. That’s especially true when it comes to investing, where trading imbalances of low-float companies can have an outsized effect on which way momentum trends. Take the case of Avalon GloboCare (NASDAQ: ALBT), a NASDAQ-listed company with only 3.22 million shares in the float that is better positioned than at any time in history to accelerate growth in 2023. Its

Low-Float Avalon GloboCare Positions For A Bullish 2023 ($ALBT) Read More »

Avalon GloboCare

Safe-T Group Ltd. Shares Extends Bull Run; YTD Increase Reaches 14% ($SFET) 

Safe-T Group Ltd. (NASDAQ, TASE: SFET) stocks’ consolidation period was relatively short-lived. In fact, the past few trading sessions have put the company stock firmly into rally territory, with shares adding another 3% to its price on Tuesday to bring YTD gains over 14%. That’s not surprising to those following SFET. Its Q3 financials were more than impressive; they were record-setting. And for those investing from a forward-looking perspective, the better news may be that the momentum generated during the

Safe-T Group Ltd. Shares Extends Bull Run; YTD Increase Reaches 14% ($SFET)  Read More »

Avalon GloboCare Partnerships And Planned Acquisition Fuel Bullish Interest ($ALBT)

Thinly traded Avalon GloboCare (NASDAQ: ALBT) stock is in play. In fact, shares moved more than 5% higher last week, touching $0.38 on higher-than-normal volume. By the way, calling ALBT shares “thinly traded” doesn’t imply that they are entirely under the radar. They certainly aren’t, as the average three-month volume before risk-off markets shows shares exchanging hands at over 200,000 per day. So, while ALBT isn’t a biotech investment secret in many respects, its value proposition may present a timely

Avalon GloboCare Partnerships And Planned Acquisition Fuel Bullish Interest ($ALBT) Read More »

Mullen Automotive Stock Consolidation Presents A Timely Opportunity ($MULN)

Mullen Automotive stock is consolidating at the $0.30 level. And that’s potentially excellent news for investors looking for attractively priced investment opportunities. MULN is one. In fact, after a series of value-creating announcements made over the past few weeks, few are arguing against the path of least resistance for MULN stock being appreciably higher. That bullish presumption is more than warranted; it’s a likely proposition considering MULN announced a series of accretive deals over the past few weeks that appear

Mullen Automotive Stock Consolidation Presents A Timely Opportunity ($MULN) Read More »

Item 9 Labs Stock Soars 77% So Far In November As Company Positions To Become Largest Franchisor In Multi-Billion Cannabis Sector ($INLB)

Item 9 Labs Corp. (OTCQX: INLB) stock is soaring in November. On Tuesday, shares touched highs not seen since September, scoring a 77% increase to $0.39 a share. The move is to be expected. SIRC is doing things differently. And in a sector that’s getting crowed that’s an excellent thing. Moreover, by changing its revenue-generating dynamic; they have positioned to earn sustainable and recurring revenues from a market opportunity trail they are blazing. And that’s not only excellent news for

Item 9 Labs Stock Soars 77% So Far In November As Company Positions To Become Largest Franchisor In Multi-Billion Cannabis Sector ($INLB) Read More »

Item 9 Labs Corp Getting Bigger, Expands Franchise Presence In Multi-Billion Dollar Cannabis Sector ($INLB)

Item 9 Labs Corp. (OTCQX: INLB). is changing a multi-billion dollar industry landscape. While it’s good for the company and those wanting its products, it’s potentially excellent news for investors as well. Yes, there are lists of companies intending intending to change industry, but the fact is that few actually can. Roadblocks to growth include lack of funding for expansion, management incapable of moving business plans forward, and, most often, limitations imposed by the products they sell. None of that’s the

Item 9 Labs Corp Getting Bigger, Expands Franchise Presence In Multi-Billion Dollar Cannabis Sector ($INLB) Read More »